|
|
MesotheliomaInNews.com - is a resource for those seeking latest news about Mesothelioma Asbestos Cancer and Attorneys
What Mesothelioma is?
Pleural mesothelioma is an increasingly common type of lung cancer brought on by exposure to asbestos. When inhaled, asbestos fibers become embedded in the pleura, or outer lining of the lungs, leaving behind scarring and lesions. These lesions and scars eventually develop into full-blown pleural mesothelioma, a deadly form of lung cancer for which there is no cure. Asbestos fibers can also settle in the abdominal region, triggering the development of peritoneal mesothelioma. This type of lung cancer is equally dangerous
Latest News
Lung Cancer Trial Targets Asbestos-Related Disease
MONDAY, July 21 (HealthDay News) -- Patients are being recruited for a clinical trial of a new targeted radiation and chemotherapy protocol for pleural mesothelioma, a cancer of the lung's lining that's almost always caused by exposure to asbestos.
Read more
News Source - HealthDay via Yahoo! News
Publish date - 16:03:40 07/21/08
F1: The full verdict in Mosley's privacy case
The full verdict handed out by The Honourable Mr Justice Eady of the London High Court in the case of Max Mosley versus News of the World
Read more
News Source - autosport.com
Publish date - 23:19:42 07/24/08
Rosetta Genomics Completes Acquisition Of Parkway Clinical Laboratories Inc.
Rosetta Genomics Ltd., a leader in the development of microRNA-based diagnostics and therapeutics, announced today that it has successfully completed the acquisition of Parkway Clinical Laboratories Inc., a privately-held company owning a CLIA-certified lab located in Bensalem, Pennsylvania, for an aggregate purchase price of $2,900,000, consisting of $1,900,000 in cash and $1,000,000 of ...
Read more
News Source - BioresearchOnline
Publish date - 17:32:01 07/24/08
HOME PAGE
Insurance players now see scope for more FDI Cos nearing 10th year of operations may look at listing option. Mumbai, July 23 The Government’s winning of the trust vote has raised the insurance industry’s hopes of seeing foreign direct investment in the sector being raised ...
Read more
News Source - The Hindu
Publish date - 18:38:13 07/24/08
HOME PAGE
IFCI, Emaar MGF in spat Bone of contention is pre-IPO deal of Rs 50 cr. New Delhi, July 24 IFCI has taken Emaar MGF to court, alleging non-refund of Rs 50 crore invested by the financial instituion in a pre-IPO placement transaction with the real estate company. ...
Read more
News Source - The Hindu
Publish date - 18:35:00 07/24/08
Lung Cancer Trial Targets Asbestos-Related Disease
MONDAY, July 21 (HealthDay News) -- Patients are being recruited for a clinical trial of a new targeted radiation and chemotherapy protocol for pleural mesothelioma, a cancer of the...
Read more
News Source - ABC 7 El Paso
Publish date - 15:19:08 07/22/08
Major asbestos suit kicks off in Tokyo
What is believed to be the biggest asbestos-related litigation in Japan opened Wednesday at the Tokyo District Court with construction workers and relatives of deceased workers taking the stand to describe years of health problems that could have been prevented. The 178 plaintiffs are demanding a combined ¥6.6 billion in compensation from 46 construction-materials manufacturers and the ...
Read more
News Source - The Japan Times
Publish date - 21:04:50 07/23/08
HOME PAGE
Guilty won’t be spared: Speaker New Delhi, July 22 The bribery scandal, in which it was alleged that three opposition Members of Parliament were offered several crores of rupees to abstain from voting on the confidence motion moved by the United Progressive Alliance (UPA) ...
Read more
News Source - The Hindu
Publish date - 18:38:37 07/23/08
Lung Cancer Trial Targets Asbestos-Related Disease
Title: Lung Cancer Trial Targets Asbestos-Related Disease Category: Health News Created: 7/22/2008 2:00:00 AM Last Editorial Review: 7/22/2008
Read more
News Source - MedicineNet.com
Publish date - 19:27:46 07/22/08
First Cancer Diagnostic Test Based On Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval
Rosetta Genomics, Ltd. (NASDQ: ROSG) announces that the first molecular test based on Rosetta Genomics' proprietary microRNA technology, developed and validated by Columbia University Medical Center (CUMC), has been approved for clinical use by the New York State Department of Health Clinical Laboratory Evaluation Program.
Read more
News Source - Medical News Today
Publish date - 11:12:49 07/23/08
HOME PAGE
Maruti Q1 net skids despite higher sales Higher input costs, new depreciation policy impact show. New Delhi, July 21 Maruti Suzuki, the country’s top car maker, posted a drop in net profit despite higher sales, mainly on account of a sharp increase in raw material prices and a ...
Read more
News Source - The Hindu
Publish date - 18:52:52 07/22/08
Lung Cancer Trial Targets Asbestos-Related Disease
Copyright © 2008 ScoutNews LLC. All rights reserved.
Read more
News Source - HealthCentral.com
Publish date - 17:09:31 07/21/08
First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval
Rosetta Genomics, Ltd. announces today that the first molecular test based on Rosetta Genomics' proprietary microRNA technology, developed and validated by Columbia University Medical Center , has been approved for clinical use by the New York State Department of Health Clinical Laboratory Evaluation Program.
Read more
News Source - PR Newswire via Yahoo! Finance
Publish date - 12:32:33 07/22/08
HOME PAGE
Petronet steps up efforts to procure more LNG Board to discuss revised deal on supply from Exxon Mobil. New Delhi, July 20 The board of Petronet LNG Ltd on Monday is likely to consider the revised deal for liquefied natural gas (LNG) from Exxon Mobil’s interest in Australia’s ...
Read more
News Source - The Hindu
Publish date - 18:53:30 07/21/08
|